- Research Grants
Luisa Matos do Canto, B.Sc., graduated in Biological Sciences from the Federal University of Santa Catarina (2010), where she acquired experience in point mutations (SNPs) analysis of autoimmune diseases. Subsequently, she improved her skills in Human and Medical Genetics while working as a research assistant at Lombardi Comprehensive Cancer Center (Georgetown University) using DNA and miRNA microarrays to study cancer biology. She obtained her PhD in the area of genetics and molecular biology of cancer in the NeoGene laboratory at the .Camargo Cancer Center in São Paulo (2018). She works as a research assistant at the Department of Genetics at Vejle Hospital in Denmark. (Source: Lattes Curriculum)
Colon and rectal tumors are different, not only regarding their location, but also in the type and frequency of genomic and epigenomic alterations. Furthermore, it has been reported different genes and pathways involved in tumors from distinct anatomic location. Colon or rectal tumor resection is recommended in early stages, and in the majority of cases is followed by chemotherapy. Howe...
Stage II-III rectal carcinoma (ReCa) patients undergo neoadjuvant chemoradiotherapy (nCRT) followed by surgery. Those who achieve pathological complete response (pCR) have better prognosis and could be spared of a highly morbid procedure if pCR was accurately identified precociously. However, the current molecular studies have shown inconclusive results. Our study aims to evaluate the g...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|